About
Gubra is a biotech company in Hørsholm, Denmark, with additional sites in Boston, United States, and Basel, Switzerland. It provides preclinical CRO services, drug discovery and development focused on peptide therapeutics, and venture creation and incubation. Its CRO work serves pharmaceutical and biotech companies worldwide.
Services
Preclinical contract research services
Preclinical studies to help pharmaceutical and biotech companies advance drug development pipelines.
Liver (MASH) studies
Validated MASH mouse models and related translational endpoints for efficacy and proof-of-concept work.
Obesity studies
Diet-induced obesity rodent models and efficacy studies with metabolic and body composition endpoints.
Kidney disease studies
Preclinical models for CKD, DKD and AKI with pharmacology, biomarkers, histology and 3D imaging.
Lung (IPF) studies
Bleomycin-induced IPF mouse models with pulmonary function, histopathology and transcriptomic readouts.
Diabetes studies
Preclinical diabetes assessment services using disease models and translational endpoints.
Women’s health studies
Preclinical studies in POI and PCOS models to assess novel compounds.
Muscle (sarcopenia) studies
Integrated muscle research platform for profiling drug candidates in sarcopenia-related work.
7 more services
- Non-rodent studies
- 3D imaging services
- 2D histology
- RNAseq services
- Peptide drug discovery
- Drug development
- Venture creation and incubation
Capabilities
- Assays and studies
- Rodent models
- Peptides
- In vivo
- Histopathology
- Small molecules
- NGS
15 more
- In vivo pharmacology
- Ex vivo assays
- Drug profiling
- 2D histology
- 3D whole brain imaging
- Whole organ imaging
- Energy expenditure
- Metabolic profiling
- Body composition
- Acute food intake monitoring
- Biomarker analysis
- Full metabolic assessment
- Biochemical assessment
- NAS scoring
- Fibrosis scoring
- Scale and capacity
- More than 300 scientists and experts
- Therapeutic areas
- Liver (MASH)
- Obesity
- Kidney
- Lung (IPF)
- CNS
- Diabetes
- Women’s Health
- Muscle (Sarcopenia)
Instruments and platforms
- AI-based histology pipeline
- Whole body plethysmography
- Spirometry
- 3D imaging technologies
- GubraView
Modalities and species
- Modalities
- Small molecule
- Antibody
- Peptide
- Viral vector
- Species and models
- Mouse
- Rat
- Miniature pig
- C57BL/6J mice
- DIO mouse
- DIO rat
8 more
- GAN DIO-MASH mouse
- CDAA-HFD mouse
- UUO mouse
- ADI CKD mouse
- uIRI mouse
- 5/6 nephrectomy rat
- ReninAAV UNx db/db mouse
- Bleomycin-induced IPF mouse
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
Company
- Type
- CRDMO
- Founded
- 2020
- Team
- More than 300 scientists and experts
- Quality
- AALAC-I accreditation (animal research program) · Quality management system (data integrity and controlled documentation)
Locations
- Office
- 2 Stonecutter Street) or via Webcast. Presentaion (PDF) Webcast video London and online In
- Sites
- Boston, United States
- Basel, Switzerland
- Serves
- Worldwide, global partners